Ron Y - Search Results

1

Human immunodeficiency virus type 1 latency model for high-throughput screening.

Micheva-Viteva S, Pacchia AL, Ron Y, Peltz SW, Dougherty JP. Micheva-Viteva S, et al. Among authors: ron y. Antimicrob Agents Chemother. 2005 Dec;49(12):5185-8. doi: 10.1128/AAC.49.12.5185-5188.2005. Antimicrob Agents Chemother. 2005. PMID: 16304201 Free PMC article.

2

Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1.

Adelson ME, Pacchia AL, Kaul M, Rando RF, Ron Y, Peltz SW, Dougherty JP. Adelson ME, et al. Among authors: ron y. Antimicrob Agents Chemother. 2003 Feb;47(2):501-8. doi: 10.1128/AAC.47.2.501-508.2003. Antimicrob Agents Chemother. 2003. PMID: 12543650 Free PMC article.

3

Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2.

Mukherjee S, Lee HL, Ron Y, Dougherty JP. Mukherjee S, et al. Among authors: ron y. J Virol. 2006 Dec;80(24):12402-7. doi: 10.1128/JVI.01709-06. Epub 2006 Oct 4. J Virol. 2006. PMID: 17020945 Free PMC article.

4

High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor.

Micheva-Viteva S, Kobayashi Y, Edelstein LC, Pacchia AL, Lee HL, Graci JD, Breslin J, Phelan BD, Miller LK, Colacino JM, Gu Z, Ron Y, Peltz SW, Dougherty JP. Micheva-Viteva S, et al. Among authors: ron y. J Biol Chem. 2011 Jun 17;286(24):21083-91. doi: 10.1074/jbc.M110.195537. Epub 2011 Apr 15. J Biol Chem. 2011. PMID: 21498519 Free PMC article.

5

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.

Miller LK, Kobayashi Y, Chen CC, Russnak TA, Ron Y, Dougherty JP. Miller LK, et al. Among authors: ron y. Retrovirology. 2013 Oct 24;10:120. doi: 10.1186/1742-4690-10-120. Retrovirology. 2013. PMID: 24156270 Free PMC article.

6

Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots.

Zhuang J, Jetzt AE, Sun G, Yu H, Klarmann G, Ron Y, Preston BD, Dougherty JP. Zhuang J, et al. Among authors: ron y. J Virol. 2002 Nov;76(22):11273-82. doi: 10.1128/jvi.76.22.11273-11282.2002. J Virol. 2002. PMID: 12388687 Free PMC article.

7

High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy.

Zhuang J, Mukherjee S, Ron Y, Dougherty JP. Zhuang J, et al. Among authors: ron y. J Virol. 2006 Jul;80(13):6706-11. doi: 10.1128/JVI.00273-06. J Virol. 2006. PMID: 16775360 Free PMC article.

8

A HIV-2-based self-inactivating vector for enhanced gene transduction.

Mukherjee S, Lee HL, Pacchia AL, Ron Y, Dougherty JP. Mukherjee S, et al. Among authors: ron y. J Biotechnol. 2007 Jan 20;127(4):745-57. doi: 10.1016/j.jbiotec.2006.08.004. Epub 2006 Sep 18. J Biotechnol. 2007. PMID: 16979253

9

Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.

Parthasarathi S, Varela-Echavarría A, Ron Y, Preston BD, Dougherty JP. Parthasarathi S, et al. Among authors: ron y. J Virol. 1995 Dec;69(12):7991-8000. doi: 10.1128/JVI.69.12.7991-8000.1995. J Virol. 1995. PMID: 7494312 Free PMC article.

10

Inducible human immunodeficiency virus type 1 packaging cell lines.

Yu H, Rabson AB, Kaul M, Ron Y, Dougherty JP. Yu H, et al. Among authors: ron y. J Virol. 1996 Jul;70(7):4530-7. doi: 10.1128/JVI.70.7.4530-4537.1996. J Virol. 1996. PMID: 8676479 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters